Observational studyAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2021

PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks.

Tim Hollstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.